5VR9
CH1/Ckappa Fab based on Matuzumab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 31-ID |
Synchrotron site | APS |
Beamline | 31-ID |
Temperature [K] | 77 |
Detector technology | CCD |
Collection date | 2015-12-09 |
Detector | RAYONIX MX225HE |
Wavelength(s) | 0.97931 |
Spacegroup name | I 41 2 2 |
Unit cell lengths | 152.046, 152.046, 220.619 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 30.000 - 2.150 |
R-factor | 0.2116 |
Rwork | 0.210 |
R-free | 0.24390 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3c08 |
RMSD bond length | 0.008 |
RMSD bond angle | 1.221 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0103) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 2.260 |
High resolution limit [Å] | 2.150 | 2.150 |
Rmerge | 0.076 | 0.551 |
Number of reflections | 70553 | 10174 |
<I/σ(I)> | 22.6 | |
Completeness [%] | 100.0 | 100 |
Redundancy | 13.7 | 12 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 294 | see publication for details |